206 related articles for article (PubMed ID: 33974888)
21. Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11).
Gururangan S; Reap E; Schmittling R; Kocak M; Reynolds R; Grant G; Onar-Thomas A; Baxter P; Pollack IF; Phillips P; Boyett J; Fouladi M; Mitchell D
Cancer Immunol Immunother; 2017 Dec; 66(12):1589-1595. PubMed ID: 28825123
[TBL] [Abstract][Full Text] [Related]
22. Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study.
Fukuoka K; Kurihara J; Shofuda T; Kagawa N; Yamasaki K; Ando R; Ishida J; Kanamori M; Kawamura A; Park YS; Kiyotani C; Akai T; Keino D; Miyairi Y; Sasaki A; Hirato J; Inoue T; Nakazawa A; Koh K; Nishikawa R; Date I; Nagane M; Ichimura K; Kanemura Y
Acta Neuropathol Commun; 2023 Sep; 11(1):153. PubMed ID: 37749662
[TBL] [Abstract][Full Text] [Related]
23. Spinal Growth Patterns After Craniospinal Irradiation in Children With Medulloblastoma.
Johnson SB; Hung J; Kapadia N; Oh KS; Kim M; Hamstra DA
Pract Radiat Oncol; 2019 Jan; 9(1):e22-e28. PubMed ID: 30036592
[TBL] [Abstract][Full Text] [Related]
24. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.
Eaton BR; Esiashvili N; Kim S; Weyman EA; Thornton LT; Mazewski C; MacDonald T; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):133-138. PubMed ID: 26700707
[TBL] [Abstract][Full Text] [Related]
25. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
Khalil EM
J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
[TBL] [Abstract][Full Text] [Related]
26. Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.
Inakoshi H; Kayamori R; Tsuchida E; Sakai K; Shibamoto Y; Wakushima H; Ogawa Y; Kobayashi M; Obara T
Radiat Med; 2003; 21(1):37-45. PubMed ID: 12801142
[TBL] [Abstract][Full Text] [Related]
27. The Quantitative and Functional Changes of Postoperative Peripheral Blood Immune Cell Subsets Relate to Prognosis of Patients with Subarachnoid Hemorrhage: A Preliminary Study.
Zhou Y; Jiang Y; Peng Y; Zhang M
World Neurosurg; 2017 Dec; 108():206-215. PubMed ID: 28866066
[TBL] [Abstract][Full Text] [Related]
28. Prolongation of radiotherapy duration is associated with inferior overall survival in patients with pediatric medulloblastoma and central nervous system primitive neuroectodermal tumors.
Baliga S; Bajaj BVM; Kabarriti R; Grassberger C; Patteson B; Yeap B; Fox JL; Garg MK; Yock TI
Pediatr Blood Cancer; 2020 Oct; 67(10):e28558. PubMed ID: 32710698
[TBL] [Abstract][Full Text] [Related]
29. Comparison of supine and prone craniospinal irradiation in children with medulloblastoma.
Verma J; Mazloom A; Teh BS; South M; Butler EB; Paulino AC
Pract Radiat Oncol; 2015; 5(2):93-8. PubMed ID: 25413414
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
Okada K; Soejima T; Sakamoto H; Hirato J; Hara J
Pediatr Blood Cancer; 2020 Nov; 67(11):e28572. PubMed ID: 32710713
[TBL] [Abstract][Full Text] [Related]
31. Embryonal brain tumors.
McGovern SL; Grosshans D; Mahajan A
Cancer J; 2014; 20(6):397-402. PubMed ID: 25415685
[TBL] [Abstract][Full Text] [Related]
32. Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
Liu IC; Holtzman AL; Rotondo RL; Indelicato DJ; Gururangan S; Cavaliere R; Carter B; Morris CG; Tavanaiepour D; Rutenberg MS
J Neurooncol; 2021 Jul; 153(3):467-476. PubMed ID: 34105033
[TBL] [Abstract][Full Text] [Related]
33. Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy.
Hartsell WF; Gajjar A; Heideman RL; Langston JA; Sanford RA; Walter A; Jones D; Chen G; Kun LE
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):15-24. PubMed ID: 9300735
[TBL] [Abstract][Full Text] [Related]
34. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.
Suzuki S; Kato T; Murakami M
J Radiat Res; 2021 Mar; 62(2):186-197. PubMed ID: 33341899
[TBL] [Abstract][Full Text] [Related]
35. Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy?
Burcu A; Nazan Ç; Özgür Ö; Serra K; Mehmet K; Serap A; Bengü D; Canan V; Haldun Ö; Savaş K; Tuncer T; Taner A; Yeşim E; Ömer K; Yavuz A
Childs Nerv Syst; 2018 Sep; 34(9):1657-1662. PubMed ID: 29868932
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
Gupta T; Maitre M; Sastri GJ; Krishnatry R; Shirsat N; Epari S; Sahay A; Chinnaswamy G; Patil V; Shetty P; Moiyadi A
J Neurooncol; 2019 Sep; 144(2):283-291. PubMed ID: 31236820
[TBL] [Abstract][Full Text] [Related]
37. Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma.
Howell RM; Giebeler A; Koontz-Raisig W; Mahajan A; Etzel CJ; D'Amelio AM; Homann KL; Newhauser WD
Radiat Oncol; 2012 Jul; 7():116. PubMed ID: 22828073
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of long-term survivors of metastatic medulloblastoma treated with reduced-dose craniospinal irradiation.
Irikura T; Fukuoka K; Nakazawa A; Ichimura K; Kurihara J; Koh K
Childs Nerv Syst; 2023 Sep; 39(9):2505-2507. PubMed ID: 37185696
[TBL] [Abstract][Full Text] [Related]
39. Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma.
Napieralska A; Brąclik I; Radwan M; Mandera M; Blamek S
Childs Nerv Syst; 2019 Feb; 35(2):267-275. PubMed ID: 30515559
[TBL] [Abstract][Full Text] [Related]
40. Pre-irradiation chemotherapy in high risk medulloblastoma.
Abd-El-Aal HH
J Egypt Natl Canc Inst; 2006 Dec; 18(4):357-62. PubMed ID: 18301459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
